RedHill Biopharma Ltd.
RDHL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5 | $6 | $20 | $29 |
| Short-Term Investments | $0 | $1 | $0 | $9 |
| Receivables | $4 | $3 | $38 | $33 |
| Inventory | $4 | $4 | $11 | $15 |
| Other Curr. Assets | $0 | $2 | $17 | $4 |
| Total Curr. Assets | $12 | $16 | $86 | $89 |
| Property Plant & Equip (Net) | $0 | $1 | $7 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $6 | $6 | $66 | $72 |
| Long-Term Investments | $0 | $0 | $0 | $16 |
| Tax Assets | $0 | $0 | -$0 | -$16 |
| Other NC Assets | $0 | $0 | $0 | $16 |
| Total NC Assets | $6 | $7 | $73 | $92 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $18 | $23 | $159 | $181 |
| Liabilities | – | – | – | – |
| Payables | $8 | $3 | $4 | $12 |
| Short-Term Debt | $1 | $1 | $116 | $3 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $37 |
| Other Curr. Liab. | $14 | $15 | $77 | $29 |
| Total Curr. Liab. | $22 | $19 | $197 | $81 |
| LT Debt | $0 | $0 | $6 | $86 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $1 | $3 | $5 |
| Total NC Liab. | $1 | $2 | $10 | $91 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $7 | $4 |
| Total Liabilities | $23 | $21 | $207 | $172 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $35 | $21 | $3 | $1 |
| Retained Earnings | -$415 | -$408 | -$434 | -$368 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $375 | $388 | $383 | $375 |
| Total Equity | -$5 | $2 | -$48 | $9 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $18 | $23 | $159 | $181 |
| Net Debt | -$4 | -$4 | $103 | $60 |